Published in J Thorac Cardiovasc Surg on February 01, 2005
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer. J Clin Oncol (2014) 2.82
Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst (2013) 2.45
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59
Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg (2015) 1.59
Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer? Interact Cardiovasc Thorac Surg (2013) 0.94
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial. J Thorac Cardiovasc Surg (2011) 0.81
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients. Clin Lung Cancer (2015) 0.80
Sublobar resection for early-stage lung cancer. Transl Lung Cancer Res (2014) 0.80
Layered superhydrophobic meshes for controlled drug release. J Control Release (2015) 0.79
Emerging treatment options in the management of non-small cell lung cancer. Lung Cancer (Auckl) (2011) 0.78
Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer. Surg Today (2011) 0.78
Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma. Oncol Rev (2014) 0.77
Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy. Front Oncol (2015) 0.75
Oesophageal carcinoma. Lancet (2013) 5.48
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg (2011) 5.14
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg (2003) 4.30
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem (2005) 3.42
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg (2007) 2.85
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Natural history of typical pulmonary carcinoid tumors: a comparison of nonsurgical and surgical treatment. Chest (2015) 2.61
Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw (2013) 2.56
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
A ribosome-associating factor chaperones tail-anchored membrane proteins. Nature (2010) 2.51
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg (2007) 2.48
Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg (2012) 2.44
Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40
A noncytotoxic DsRed variant for whole-cell labeling. Nat Methods (2008) 2.34
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg (2012) 2.14
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg (2006) 2.12
A rapidly maturing far-red derivative of DsRed-Express2 for whole-cell labeling. Biochemistry (2009) 2.12
Lung cancer screening: conundrum or contumacy? Chest (2002) 2.04
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg (2003) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Tail-anchored membrane protein insertion into the endoplasmic reticulum. Nat Rev Mol Cell Biol (2011) 1.95
The structural basis of tail-anchored membrane protein recognition by Get3. Nature (2009) 1.94
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg (2004) 1.93
Minimally invasive operation for esophageal diverticula. Ann Thorac Surg (2005) 1.90
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
The mechanism of membrane-associated steps in tail-anchored protein insertion. Nature (2011) 1.84
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. J Clin Oncol (2010) 1.83
Outcomes after a decade of laparoscopic giant paraesophageal hernia repair. J Thorac Cardiovasc Surg (2009) 1.75
Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest (2004) 1.74
Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw (2014) 1.71
Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 1.68
Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg (2009) 1.68
Cervical pharyngostomy: an old technique revisited. Ann Surg (2008) 1.63
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res (2008) 1.63
The laparoscopic approach to paraesophageal hernia repair. J Gastrointest Surg (2011) 1.62
Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol (2007) 1.60
Resection for esophageal cancer: strategies for optimal management. Ann Thorac Surg (2008) 1.60
Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg (2012) 1.60
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59
Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51
Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine (2011) 1.48
Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis (2007) 1.46
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Should endobronchial ultrasonography be part of the thoracic surgeon's armamentarium? J Thorac Cardiovasc Surg (2009) 1.45
Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg (2008) 1.44
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc (2008) 1.43
Clinical significance of radiologic characterizations in COPD. COPD (2009) 1.41
Contemporaneous management of esophageal perforation. Surgery (2009) 1.41
Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg (2011) 1.41
Practitioner and patient perceptions of orthodontic treatment: is the patient always right? J Esthet Restor Dent (2011) 1.40
Anterior minithoracotomy: a direct approach to the difficult hilum for upper lobectomy, pneumonectomy, and sleeve lobectomy. Ann Surg Oncol (2009) 1.38
Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy. Ann Thorac Surg (2009) 1.37
Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A (2010) 1.37
Technique of minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2010) 1.32
Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg (2007) 1.31
Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem (2007) 1.30
Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg (2006) 1.28
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg (2005) 1.27
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw (2007) 1.26
General dentists' evaluation of anesthesia sedation education in U.S. dental schools. J Dent Educ (2006) 1.26
Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? Cancer (2010) 1.25
Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg (2008) 1.24
Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Hum Pathol (2004) 1.24
Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.23
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia (2006) 1.22
Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg (2012) 1.21
Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom (2010) 1.21
Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg (2009) 1.21